Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

NCT00534261 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

284

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Interferon beta-1a

Sponsor

Biogen